0001360442 --12-31 false 2026 Q3 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure 0001360442 2026-01-01 2026-09-30 0001360442 2026-09-30 0001360442 2025-12-31 0001360442 2026-07-01 2026-09-30 0001360442 2025-07-01 2025-09-30 0001360442 2025-01-01 2025-09-30 0001360442 us-gaap:PreferredStockMember 2026-01-01 2026-09-30 0001360442 us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001360442 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-09-30 0001360442 fil:WarrantEquityMember 2026-01-01 2026-09-30 0001360442 us-gaap:RetainedEarningsMember 2026-01-01 2026-09-30 0001360442 fil:NonControllingInterestPrestocorpMember 2026-01-01 2026-09-30 0001360442 fil:NonControllingInterestCoinsIncMember 2026-01-01 2026-09-30 0001360442 2025-06-30 0001360442 us-gaap:PreferredStockMember 2025-06-30 0001360442 us-gaap:CommonStockMember 2025-06-30 0001360442 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001360442 fil:WarrantEquityMember 2025-06-30 0001360442 us-gaap:RetainedEarningsMember 2025-06-30 0001360442 fil:NonControllingInterestPrestocorpMember 2025-06-30 0001360442 fil:NonControllingInterestCoinsIncMember 2025-06-30 0001360442 us-gaap:PreferredStockMember 2025-07-01 2025-09-30 0001360442 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001360442 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001360442 fil:WarrantEquityMember 2025-07-01 2025-09-30 0001360442 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001360442 fil:NonControllingInterestPrestocorpMember 2025-07-01 2025-09-30 0001360442 fil:NonControllingInterestCoinsIncMember 2025-07-01 2025-09-30 0001360442 2025-09-30 0001360442 us-gaap:PreferredStockMember 2025-09-30 0001360442 us-gaap:CommonStockMember 2025-09-30 0001360442 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001360442 fil:WarrantEquityMember 2025-09-30 0001360442 us-gaap:RetainedEarningsMember 2025-09-30 0001360442 fil:NonControllingInterestPrestocorpMember 2025-09-30 0001360442 fil:NonControllingInterestCoinsIncMember 2025-09-30 0001360442 2026-06-30 0001360442 us-gaap:PreferredStockMember 2026-06-30 0001360442 us-gaap:CommonStockMember 2026-06-30 0001360442 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001360442 fil:WarrantEquityMember 2026-06-30 0001360442 us-gaap:RetainedEarningsMember 2026-06-30 0001360442 fil:NonControllingInterestPrestocorpMember 2026-06-30 0001360442 fil:NonControllingInterestCoinsIncMember 2026-06-30 0001360442 us-gaap:PreferredStockMember 2026-07-01 2026-09-30 0001360442 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0001360442 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0001360442 fil:WarrantEquityMember 2026-07-01 2026-09-30 0001360442 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0001360442 fil:NonControllingInterestPrestocorpMember 2026-07-01 2026-09-30 0001360442 fil:NonControllingInterestCoinsIncMember 2026-07-01 2026-09-30 0001360442 us-gaap:PreferredStockMember 2026-09-30 0001360442 us-gaap:CommonStockMember 2026-09-30 0001360442 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0001360442 fil:WarrantEquityMember 2026-09-30 0001360442 us-gaap:RetainedEarningsMember 2026-09-30 0001360442 fil:NonControllingInterestPrestocorpMember 2026-09-30 0001360442 fil:NonControllingInterestCoinsIncMember 2026-09-30 0001360442 2024-12-31 0001360442 us-gaap:PreferredStockMember 2024-12-31 0001360442 us-gaap:CommonStockMember 2024-12-31 0001360442 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001360442 fil:WarrantEquityMember 2024-12-31 0001360442 us-gaap:RetainedEarningsMember 2024-12-31 0001360442 fil:NonControllingInterestPrestocorpMember 2024-12-31 0001360442 fil:NonControllingInterestCoinsIncMember 2024-12-31 0001360442 us-gaap:PreferredStockMember 2025-01-01 2025-09-30 0001360442 us-gaap:CommonStockMember 2025-01-01 2025-09-30 0001360442 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-09-30 0001360442 fil:WarrantEquityMember 2025-01-01 2025-09-30 0001360442 us-gaap:RetainedEarningsMember 2025-01-01 2025-09-30 0001360442 fil:NonControllingInterestPrestocorpMember 2025-01-01 2025-09-30 0001360442 fil:NonControllingInterestCoinsIncMember 2025-01-01 2025-09-30 0001360442 us-gaap:PreferredStockMember 2025-12-31 0001360442 us-gaap:CommonStockMember 2025-12-31 0001360442 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001360442 fil:WarrantEquityMember 2025-12-31 0001360442 us-gaap:RetainedEarningsMember 2025-12-31 0001360442 fil:NonControllingInterestPrestocorpMember 2025-12-31 0001360442 fil:NonControllingInterestCoinsIncMember 2025-12-31 0001360442 fil:N2023AgreementMemberfil:Director1Member 2026-01-01 2026-09-30 0001360442 us-gaap:WarrantMember 2026-01-01 2026-09-30 0001360442 us-gaap:WarrantMember 2025-01-01 2025-09-30 0001360442 us-gaap:ConvertibleDebtSecuritiesMember 2026-01-01 2026-09-30 0001360442 us-gaap:ConvertibleDebtSecuritiesMember 2025-01-01 2025-12-31 0001360442 fil:CannabisSativaMemberus-gaap:InternetDomainNamesMember 2026-09-30 0001360442 fil:CannabisSativaMemberus-gaap:InternetDomainNamesMember 2025-12-31 0001360442 fil:PrestocorpMemberus-gaap:IntellectualPropertyMember 2026-09-30 0001360442 fil:PrestocorpMemberus-gaap:IntellectualPropertyMember 2025-12-31 0001360442 fil:KPALMemberfil:PatentsAndTrademarksMember 2026-09-30 0001360442 fil:KPALMemberfil:PatentsAndTrademarksMember 2025-12-31 0001360442 fil:PrestocorpMember 2017-08-01 2017-08-01 0001360442 fil:PrestocorpMember 2026-09-30 0001360442 fil:PrestocorpMember 2025-12-31 0001360442 fil:N2DirectorsMember 2026-09-30 0001360442 fil:N2DirectorsMember 2025-12-31 0001360442 fil:ChiefExecutiveOfficerAndDirectorMember 2026-07-01 2026-09-30 0001360442 fil:ChiefExecutiveOfficerAndDirectorMember 2025-07-01 2025-09-30 0001360442 fil:ConsultingFeesMemberfil:ChiefExecutiveOfficerAndDirectorMember 2026-09-30 0001360442 fil:ConsultingFeesMemberfil:ChiefExecutiveOfficerAndDirectorMember 2025-12-31 0001360442 fil:ConsultingFeesMemberfil:PriorChiefFinancialOfficerMember 2026-09-30 0001360442 fil:ConsultingFeesMemberfil:PriorChiefFinancialOfficerMember 2025-12-31 0001360442 fil:DirectorsFees1Memberfil:PriorChiefFinancialOfficerMember 2026-09-30 0001360442 fil:DirectorsFees1Memberfil:PriorChiefFinancialOfficerMember 2025-12-31 0001360442 fil:PriorChiefFinancialOfficerMember 2026-09-30 0001360442 fil:PriorChiefFinancialOfficerMember 2025-12-31 0001360442 fil:ConsultingFeesMemberfil:ChiefOperatingOfficer1Member 2026-09-30 0001360442 fil:ConsultingFeesMemberfil:ChiefOperatingOfficer1Member 2025-12-31 0001360442 fil:ChiefOperatingOfficer1Member 2026-09-30 0001360442 fil:ChiefOperatingOfficer1Member 2025-12-31 0001360442 fil:Director1Member 2026-01-01 2026-09-30 0001360442 fil:Director1Member 2025-01-01 2025-09-30 0001360442 fil:ChiefExecutiveOfficerAndDirectorMember 2024-01-01 2024-12-31 0001360442 fil:ChiefExecutiveOfficerAndDirectorMember 2026-01-01 2026-09-30 0001360442 fil:Director1Member 2024-01-01 2024-12-31 0001360442 fil:Director1Member 2025-01-01 2025-12-31 0001360442 fil:RelatedPartyNotePayableMember 2026-09-30 0001360442 fil:RelatedPartyNotePayableMember 2025-09-30 0001360442 fil:RelatedPartyNotePayableMember 2026-07-01 2026-09-30 0001360442 fil:RelatedPartyNotePayableMember 2025-07-01 2025-09-30 0001360442 fil:RelatedPartyNotePayableMember 2026-01-01 2026-09-30 0001360442 fil:RelatedPartyNotePayableMember 2025-01-01 2025-09-30 0001360442 fil:ChiefExecutiveOfficerAndDirectorMember 2026-09-30 0001360442 fil:Director1Member 2026-09-30 0001360442 fil:Director2Member 2026-09-30 0001360442 fil:StockPayable1Member 2026-09-30 0001360442 fil:ChiefExecutiveOfficerAndDirectorMember 2025-12-31 0001360442 fil:Director1Member 2025-12-31 0001360442 fil:Director2Member 2025-12-31 0001360442 fil:StockPayable1Member 2025-12-31 0001360442 fil:MjHarvestIncMember 2025-12-31 0001360442 fil:CBDGMemberus-gaap:CommonStockMember 2021-01-01 2021-12-31 0001360442 fil:CBDGMember 2021-12-31 0001360442 fil:CBDGMember 2021-01-01 2021-12-31 0001360442 fil:CBDGMember 2026-09-30 0001360442 fil:CBDGMember 2025-12-31 0001360442 fil:CBDGMember 2026-07-01 2026-09-30 0001360442 fil:CBDGMember 2025-07-01 2025-09-30 0001360442 fil:CBDGMember 2026-01-01 2026-09-30 0001360442 fil:CBDGMember 2025-01-01 2025-09-30 0001360442 fil:DogTokensMember 2026-01-01 2026-09-30 0001360442 fil:DogTokensMember 2026-09-30 0001360442 fil:DogTokensMember 2025-12-31 0001360442 fil:DogTokensMember 2026-07-01 2026-09-30 0001360442 fil:DogTokensMember 2025-07-01 2025-09-30 0001360442 fil:DogTokensMember 2025-01-01 2025-09-30 0001360442 fil:May222025AgreementMember 2026-01-01 2026-09-30 0001360442 fil:May222025AgreementMemberus-gaap:CommonStockMember 2025-05-22 2025-05-22 0001360442 fil:June252025AgreementMember 2026-01-01 2026-09-30 0001360442 fil:October292025AgreementMember 2026-01-01 2026-09-30 0001360442 fil:ConvertibleNotesPayable1Member 2026-09-30 0001360442 fil:ConvertibleNotesPayable1Member 2025-12-31 0001360442 fil:ConvertibleNotesPayable1Member 2026-07-01 2026-09-30 0001360442 fil:ConvertibleNotesPayable1Member 2025-07-01 2025-09-30 0001360442 fil:ConvertibleNotesPayable1Member 2026-01-01 2026-09-30 0001360442 fil:ConvertibleNotesPayable1Member 2025-01-01 2025-09-30 0001360442 fil:Conversion1Memberus-gaap:CommonStockMember 2025-01-01 2025-09-30 0001360442 fil:Conversion1Member 2026-09-30 0001360442 fil:Conversion1Member 2026-01-01 2026-09-30 0001360442 2026-04-01 2026-06-30 0001360442 us-gaap:CommonStockMember 2025-01-01 2025-12-31 0001360442 2025-01-01 2025-12-31 0001360442 fil:WarrantEquityMember 2025-01-01 2025-12-31

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

___________________

 

FORM 10-Q

___________________

 

☒

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

For the quarterly period ended: September 30, 2026

 

or

 

 

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

For the transition period from: _____________ to _____________

 

Commission File Number: 000-53571

 

 

Dogecoin Cash, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada

 

20-1898270

(State or Other Jurisdiction

 

(I.R.S. Employer

of Incorporation)

 

Identification No.)

 


 

355 W. Mesquite Blvd. #C-70

Mesquite, Nevada 89027

(Address of Principal Executive Office) (Zip Code)

 

(702) 762-3123

(Registrant’s telephone number, including area code)

 

N/A

(Former name, former address, and former fiscal year, if changed since last report)

———————

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol

Name of each exchange on which registered.

None

 

 

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ☒ Yes ☐ No


 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

☐

Accelerated filer

☐

Non-accelerated Filer

☐

Smaller reporting company

☒

Emerging growth company

☒

 

 

 

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

 

The number of shares of the issuer’s Common Stock outstanding as of September 30, 2026 is 166,905,766.

 


 

PART I—FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

Attached after signature page.

 

Item 1C. Cybersecurity

 

We recognize the critical importance of developing, implementing, and maintaining robust cybersecurity measures to safeguard our information systems and protect the confidentiality, integrity, and availability of our data. We currently have security measures in place to protect our clients, customers, employees,‌ and vendor information and prevent data loss and other security breaches. We only use third party software for accounting, billing and payroll that has robust compliance and is actively involved in continuous assessment of risks from cybersecurity threats, including prevention, mitigation, detection, and remediation of cybersecurity incidents.

 

Our CEO is responsible for overseeing our business operations and is responsible for day-to-day assessment and confers weekly with subsidiary webmaster to understand any risks from cybersecurity threats, including the prevention, mitigation, detection, and remediation of cybersecurity incidents.

 

As our core operations are virtual, it is routine to undertake activities to prevent, detect, and minimize the effects of cybersecurity incidents, maintain business continuity, contingency, and have recovery plans for use in the event of a cybersecurity incident by the administering of local and cloud based back up of files and emails. We currently do not carry a cyber liability insurance policy but are evaluating whether to acquire one to mitigate any financial impact of a cybersecurity breach.


4


 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Certain statements in this Report constitute “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Factors that might cause such a difference include, among others, uncertainties relating to general economic and business conditions; industry trends; changes in demand for our products and services; uncertainties relating to customer plans and commitments and the timing of orders received from customers; announcements or changes in our pricing policies or that of our competitors; unanticipated delays in the development, market acceptance or installation of our products and services; changes in government regulations; availability of management and other key personnel; availability, terms, and deployment of capital; relationships with third-party equipment suppliers; and worldwide political stability and economic growth. The words “believe,” “expect,” “anticipate,” “intend” and “plan” and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made.


5


 

Results of Operations

 

Three Months Ended September 30, 2026 compared with the Three Months Ended September 30, 2025

 

  

 

Three Months Ended

 

 

 

A

 

 

B

 

 

A-B

 

 

 

September 30,

2026

 

 

September 30,

2025

 

 

Change

 

 

Change %

 

REVENUE

 

$

164,420 

 

 

$

190,564 

 

 

$

(26,144) 

 

 

 

(14)

%

Cost of revenues

 

 

59,595

 

 

 

68,615 

 

 

 

(9,020) 

 

 

 

(13)

%

Cost of sales % of total sales

 

 

36 

%

 

 

36

%

 

 

0 

 %

 

 

1 

%

Gross profit

 

 

104,825 

 

 

 

121,949 

 

 

 

(17,124)

 

 

 

(14)

%

Gross profit % of sales

 

 

64

%

 

 

64 

%

 

 

 

 

 

 

 

EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Professional fees

 

 

29,924 

 

 

 

70,309 

 

 

 

(40,385)

 

 

 

(57)

%

Depreciation and amortization

 

 

233 

 

 

 

301 

 

 

 

(68)

 

 

 

(23)

%

Wages and salaries

 

 

65,111 

 

 

 

77,878 

 

 

 

(12,767)

 

 

 

(16)

%

Advertising

 

 

265 

 

 

 

394 

 

 

 

(129)

 

 

 

(33)

%

General and administrative

 

 

104,781

 

 

 

120,236 

 

 

 

(15,455)

 

 

 

(13)

%

Total expenses

 

 

200,314

 

 

 

269,118

 

 

 

(68,804)

 

 

 

(26)

%

NET LOSS FOR THE PERIOD FROM CONTINUING OPERATIONS

 

 

(95,489)

 

 

 

(147,169)

 

 

 

51,680

 

 

 

35

%

Other Income and (Expenses)

 

 

267,185

 

 

 

(31,274)

 

 

 

298,459

 

 

 

954

%

Net Income (Loss) for the Period

 

 

171,696

 

 

$

(178,443)

 

 

$

350,139

 

 

 

196

%

 

Revenue for the three months ended September 30, 2026, decreased 14% compared to the three months ended September 30, 2025. Cost of revenues as a percentage of sales decreased 13% between the periods. The 14% revenue decrease was the result of sustained


6


competitive pressure in the cannabis tele-medicine industry, where intensifying market competition has compressed demand growth through the third quarter of 2026.

 

Total operating expenses decreased 26% to $200,314 for the three months ended September 30, 2026, compared to $269,118 in Q3 2025. The decrease was driven by a 33% decrease in advertising, a 13% decrease in general and administrative expenses, a 16% decrease in wages and salaries and a 57% decrease in professional fees.

 

Other income and (expenses) decreased 954% to $267,185 for the three months ended September 30, 2026, compared to $(31,274) in Q3 2025. The decrease was driven by an increase in unrealized gain on investments of $200,672, gain on change in convertible component in convertible loans of $107,617, loss on debt settlement of $(38,241) a decrease in officer short swing profit of $(18,557) and a decrease in interest expense of $46,968.


7


 

Nine Months Ended September 30, 2026 compared with the Nine Months Ended September 30, 2025

 

  

 

Nine Months Ended

 

 

 

A

 

 

B

 

 

A-B

 

 

 

September 30,

2026

 

 

September 30,

2025

 

 

Change

 

 

Change %

 

REVENUE

 

$

523,829

 

 

$

567,501

 

 

$

(43,672)

 

 

 

(8)

%

Cost of revenues

 

 

188,265

 

 

 

207,109

 

 

 

(18,844)

 

 

 

(9)

%

Cost of sales % of total sales

 

 

36

%

 

 

36 

%

 

 

(1)

 %

 

 

(2)

%

Gross profit

 

 

335,564

 

 

 

360,392

 

 

 

(24,828) 

 

 

 

(3)

%

Gross profit % of sales

 

 

64 

%

 

 

64 

%

 

 

 

 

 

 

 

EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Professional fees

 

 

159,366

 

 

 

149,221

 

 

 

10,145

 

 

 

7 

%

Depreciation and amortization

 

 

813

 

 

 

904

 

 

 

(91)

 

 

 

(10)

%

Wages and salaries

 

 

200,723

 

 

 

227,295

 

 

 

(26,572)

 

 

 

(12)

%

Advertising

 

 

3,486

 

 

 

2,893

 

 

 

593

 

 

 

20 

%

General and administrative

 

 

336,822

 

 

 

412,278

 

 

 

(75,456)

 

 

 

(18)

%

Total expenses

 

 

701,210

 

 

 

792,591

 

 

 

(91,381)

 

 

 

(12)

%

NET LOSS FOR THE PERIOD FROM CONTINUING OPERATIONS

 

 

(365,646)

 

 

 

(432,199)

 

 

 

66,553 

 

 

 

15

%

Other Income and (Expenses)

 

 

(145,062)

 

 

 

(7,148,942)

 

 

 

7,003,880

 

 

 

98

%

Net Loss for the Period

 

$

(510,708)

 

 

$

(7,581,141)

 

 

$

7,070,433

 

 

 

93

%

 

Revenue for the nine months ended September 30, 2026, decreased 8% compared to the nine months ended September 30, 2025. Cost of revenues as a percentage of sales decreased 1% between the periods. The decrease in revenues is primarily a result of the


8


significant increase in competition for market share in the cannabis tele-medicine industry. This decrease in the demand for our service continued during the third quarter of 2026.

 

Total operating expenses decreased September 30, 2026 compared with 2025 which trended down as did revenue in the current period. Increases in professional fees were offset by decreases in wages and salaries and general and administrative expenses. PrestoDoctor management salaries also decreased during the nine months ended September 30, 2026.

 

Other income and (expenses) decreased 98% to $(145,062) for the nine months ended September 30, 2026, compared to $(7,148,942) in the nine months ended September 30, 2025. The decrease was driven by an increase in unrealized loss on investments of $184,506, decrease in impairment expense- digital currency of $7,079,850 and increase in loss on debt settlement of $21,541 and increase in gain on change in convertible component in convertible loans of $107,514, a decrease in officer short swing profit of $18,557 and a decrease in interest expense of $41,120.

 

4. Liquidity and Capital Resources

 

Cash used in operating activities was $24,103 for the nine months ended September 30, 2026. We ended the third quarter of 2026 with $9,485 cash on hand.

 

The accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. We incurred net losses of $510,708 and $7,581,141, respectively, for the nine months ended September 30, 2026 and 2025 and had an accumulated deficit of $84,948,411 as of September 30, 2026. The Company may seek to raise money for working capital purposes through a public offering of its equity capital or through a private placement of equity capital or convertible debt. It will be important for the Company to be successful in its efforts to raise capital in this manner if it is going to be able to further its business plan in an aggressive manner. Raising capital in this manner will cause dilution to current shareholders.

 

The amount of cash on hand the Company has does not provide sufficient liquidity to meet the immediate needs of our current operations.

 

Off Balance Sheet Arrangements

 

None


9


Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

Not required.

 

Item 4. Controls and Procedures.

 

Disclosure Controls and Procedures

 

Conclusions of Management Regarding Effectiveness of Disclosure Controls and Procedures

 

At the end of the period covered by this Quarterly Report on Form 10-Q, an evaluation was carried out under the supervision and with the participation of the Company’s management, including the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the effectiveness of the design and operations of the Company’s disclosure controls and procedures (as defined in Rule 13a – 15(e) and Rule 15d – 15(e) under the Exchange Act). Based on that evaluation, the CEO and the CFO have concluded that as of the end of the period covered by this report, the Company’s disclosure controls and procedures were not effective as it was determined that there were material weaknesses affecting our disclosure controls and procedures.

 

Management of the Company believes that these material weaknesses are due to the small size of the company’s accounting staff. The small size of the Company’s accounting staff may prevent adequate controls in the future, such as segregation of duties, due to the cost/benefit of remediation. To mitigate the current limited resources and limited employees, we rely heavily on direct management oversight of transactions, along with the use of external legal and accounting professionals. As the Company grows, management expects to increase the number of employees, which will enable us to implement adequate segregation of duties within the internal control framework.

 

Changes in Internal Control over Financial Reporting

 

There was no change in our internal control over financial reporting during the quarter ended September 30, 2026, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.


10


 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

We are not a party to any material legal proceedings, and, to the best of our knowledge, no such legal proceedings have been threatened against us.

 

Item 1A. Risk Factors

 

Not required.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

None

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

None.


11


 

Item 6. Exhibits.

 

The following documents are included as exhibits to this report:

(a)Exhibits 

Exhibit

Number

 

SEC

Reference

Number

 

Title of Document

 

Notes

 

 

 

 

 

 

 

3.1

 

3

 

Articles of Incorporation

 

(1)

3.2

 

3

 

Bylaws

 

(1)

31.1

 

31

 

Section 302 Certification of Principal Executive Officer

 

 

31.2

 

31

 

Section 302 Certification of Principal Financial Officer

 

 

32.1

 

32

 

Section 1350 Certification of Principal Executive Officer

 

 

32.2

 

32

 

Section 1350 Certification of Principal Financial Officer

 

 

101.INS

 

 

 

XBRL Instance Document

 

(2)

101.SCH

 

 

 

XBRL Taxonomy Extension Schema

 

(2)

101.CAL

 

 

 

XBRL Taxonomy Extension Calculation Linkbase

 

(2)

101.DEF

 

 

 

XBRL Taxonomy Extension Definition Linkbase

 

(2)

101.LAB

 

 

 

XBRL Taxonomy Extension Label Linkbase

 

(2)

101.PRE

 

 

 

XBRL Taxonomy Extension Presentation Linkbase

 

(2)

 

(1) Incorporated by reference to the Company’s Articles of Incorporation, as amended, and Bylaws previously filed with the Securities and Exchange Commission.

(2) XBRL information is furnished and not filed for purposes of Sections 11 and 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934, and is not subject to liability under those sections, is not part of any registration statement or prospectus to which it relates and is not incorporated or deemed to be incorporated by reference into any registration statement, prospectus or other document.  


12


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dogecoin Cash, Inc.

 

Date: November 20, 2026

 

By:  

/s/ David Tobias

 

 

David Tobias

Principal Executive Officer

Principal Financial Officer

 

 

 


13


 

DOGECOIN CASH, INC.

 

 

 

 

 

 

 

CONDENSED CONSOLIDATED BALANCE SHEETS - UNAUDITED

 

 

 

 

 

 

 

September 30,

 

December 31,

 

2026

 

2025

ASSETS

 

 

 

Current Assets

 

 

 

Cash

$9,485 

 

$29,553  

Investment in equity securities, at fair value

739,354 

 

915,310  

 

 

 

 

Total Current Assets

748,839 

 

944,863  

 

 

 

 

 

 

 

 

Advances to related parties, net of allowance for bad debts

1,850 

 

1,250  

Property and equipment, net

1,799 

 

1,912  

Intangible assets, net

2,572 

 

3,271  

Goodwill

1,275,811 

 

1,275,811  

 

 

 

 

Total Assets

$2,030,871 

 

$2,227,107  

 

 

 

 

LIABILITIES AND STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

Current Liabilities

 

 

 

Accounts payable and accrued expenses

$224,599 

 

$190,469  

Accrued interest - related parties

54,260 

 

42,286  

Fair value of convertible component in convertible loans

66,770 

 

174,387  

Convertible notes payable

159,918 

 

183,270  

Notes payable to related parties

291,818 

 

249,683  

 

 

 

 

Total Current Liabilities

797,365 

 

840,095  

 

 

 

 

Long-term liabilities

 

 

 

Stock payable

1,669,172 

 

1,416,047  

 

 

 

 

Total Liabilities

2,466,537 

 

2,256,142  

 

 

 

 

Commitments and contingencies (Notes 6 and 8)

 

 

 

 

 

 

 

Stockholders' Deficit

 

 

 

Preferred Stock $0.001 par value; 5,000,000 shares authorized; 4,652,675 shares issued and outstanding, respectively

4,653 

 

4,653  

Common stock $0.001 par value; 495,000,000 shares authorized; 166,905,766 and 160,109,031 shares issued and outstanding, respectively

166,905 

 

160,108  

Additional paid-in capital

82,435,214 

 

82,337,934  

Warrant equity

18,702 

 

18,702  

Accumulated deficit

(84,948,411) 

 

(84,389,964) 

 

 

 

 

Total Dogecoin Cash Inc. Stockholders' Deficit

(2,322,937) 

 

(1,868,567) 

 

 

 

 

Non-Controlling Interest

1,887,271 

 

1,839,532  

 

 

 

 

Total Stockholders' Deficit

(435,666) 

 

(29,035) 

 

 

 

 

Total Liabilities and Stockholders' Deficit

$2,030,871 

 

$2,227,107  

 

 

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 


F-1


DOGECOIN CASH, INC.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - UNAUDITED

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the three and nine months ended September 30,

 

2026

 

2025

 

2026

 

2025

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

 

 

$164,420  

 

$190,564  

 

$523,829  

 

$567,501  

 

 

 

 

 

 

 

 

 

 

 

Cost of Revenues

 

 

 

59,595  

 

68,615  

 

188,265  

 

207,109  

 

 

 

 

 

 

 

 

 

 

 

Gross Profit

 

 

 

104,825  

 

121,949  

 

335,564  

 

360,392  

 

 

 

 

 

 

 

 

 

 

 

Operating Expenses

 

 

 

 

 

 

 

 

 

 

Professional fees

 

 

 

29,924  

 

70,309  

 

159,366  

 

149,221  

Depreciation and amortization

 

 

 

233  

 

301  

 

813  

 

904  

Wages and salaries

 

 

 

65,111  

 

77,878  

 

200,723  

 

227,295  

Advertising

 

 

 

265  

 

394  

 

3,486  

 

2,893  

General and administrative

 

 

 

104,781  

 

120,236  

 

336,822  

 

412,278  

 

 

 

 

 

 

 

 

 

 

 

Total Operating Expenses

 

 

 

200,314  

 

269,118  

 

701,210  

 

792,591  

 

 

 

 

 

 

 

 

 

 

 

Loss from Operations

 

 

 

(95,489) 

 

(147,169) 

 

(365,646) 

 

(432,199) 

 

 

 

 

 

 

 

 

 

 

 

Other Income and (Expenses)

 

 

 

 

 

 

 

 

 

 

Officer short swing profit repayment

 

 

 

-  

 

18,557  

 

-  

 

18,557  

Unrealized gain (loss) on investment

 

 

 

208,772  

 

8,100  

 

(175,956) 

 

8,550  

Impairment expense - digital currency

 

 

 

-  

 

-  

 

-  

 

(7,079,850) 

Loss on debt settlement

 

 

 

(38,241) 

 

-  

 

(38,241) 

 

(16,700) 

Change in fair value of convertible component in convertible loans

 

 

 

107,617  

 

-  

 

107,617  

 

103  

Interest expense

 

 

 

(10,963) 

 

(57,931) 

 

(38,482) 

 

(79,602) 

 

 

 

 

 

 

 

 

 

 

 

Total Other Income and (Expenses), Net

 

 

 

267,185  

 

(31,274) 

 

(145,062) 

 

(7,148,942) 

 

 

 

 

 

 

 

 

 

 

 

Income (Loss) Before Income Taxes

 

 

 

171,696 

 

(178,443) 

 

(510,708) 

 

(7,581,141) 

 

 

 

 

 

 

 

 

 

 

 

Income Taxes

 

 

 

-  

 

-  

 

-  

 

-  

 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss) for the Period

 

 

 

171,696 

 

(178,443) 

 

(510,708) 

 

(7,581,141) 

 

 

 

 

 

 

 

 

 

 

 

Income (Loss) attributable to non-controlling interest - PrestoCorp and Meme Coins Inc.

 

 

 

160,409  

 

(5,344) 

 

47,738  

 

(7,091,938) 

 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss) for the Period Attributable To DogeCoin Cash, Inc.

 

 

 

$11,287  

 

$(173,099) 

 

$(558,446) 

 

$(489,203) 

 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss) for the Period per Common Share: Basic & Diluted

 

$0.00  

 

$(0.00) 

 

$(0.00) 

 

$(0.00) 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average Common Shares Outstanding:

 

 

 

 

 

 

 

 

 

 

Basic & Diluted

 

 

 

163,486,859  

 

153,891,578  

 

162,770,709  

 

147,682,198  

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.


F-2


 

DOGECOIN CASH, INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025 - UNAUDITED

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

Non-controlling

 

Non-controlling

 

 

 

 

 

Preferred Stock

 

Common Stock

 

Paid-In

 

Warrant

 

Accumulated

 

Interest -

 

Interest -

 

 

 

Three Months Ended September 30, 2025

 

Shares

 

Amount

 

Shares

 

Amount

 

Capital

 

Equity

 

Deficit

 

Prestocorp

 

Meme Coins Inc

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance - July 1, 2025

 

4,652,673

 

$4,653 

 

148,947,862

 

$148,948 

 

$82,260,016 

 

$-  

 

$(84,132,677) 

 

$1,303,228  

 

$420,150  

$4,318  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preferred stock dividend issued

 

2

 

- 

 

-

 

- 

 

- 

 

-  

 

-  

 

-  

 

-  

-  

 

 

Value of cashless warrants exercised

 

-

 

- 

 

-

 

- 

 

- 

 

45,280  

 

-  

 

-  

 

-  

45,280  

 

 

Common stock issued for services in stock payable

 

-

 

- 

 

3,968,254

 

3,968 

 

58,532 

 

-  

 

-  

 

-  

 

-  

62,500  

 

 

Common stock issued for exercised cashless warrants

 

-

 

- 

 

7,192,913

 

7,192 

 

19,386 

 

(26,578) 

 

-  

 

-  

 

-  

-  

 

 

Net loss for the period

 

-

 

- 

 

-

 

- 

 

- 

 

-  

 

(173,099) 

 

(5,344) 

 

-  

(178,443) 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance - September 30, 2025

 

4,652,675

 

$4,653 

 

160,109,029

 

$160,108 

 

$82,337,934 

 

$18,702  

 

$(84,305,776) 

 

$1,297,884  

 

$420,150  

$(66,345) 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30, 2026

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance - July 1, 2026 – Restated (Note 10)

 

4,652,675

 

$4,653 

 

162,609,029

 

$162,608 

 

$82,381,934 

 

$18,702  

 

$(84,959,698) 

 

$1,278,162  

 

$448,700  

$(664,939) 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued - notes payable conversion

 

-

 

- 

 

4,296,737

 

4,297 

 

53,280 

 

-  

 

-  

 

-  

 

-  

57,577  

 

 

Net income (loss) for the period

 

-

 

- 

 

-

 

- 

 

- 

 

-  

 

11,287  

 

(4,791) 

 

165,200  

171,696  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance - September 30, 2026

 

4,652,675

 

$4,653 

 

166,905,766

 

$166,905 

 

$82,435,214 

 

$18,702  

 

$(84,948,411) 

 

$1,273,371  

 

$613,900  

$(435,666) 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended September 30, 2025

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance - January 1, 2025

 

4,500,000

 

$4,500 

 

143,903,921

 

$143,904 

 

$82,229,325 

 

-  

 

$(83,816,573) 

 

$1,309,972  

 

$-  

$(128,872) 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued - notes payable conversion

 

-

 

- 

 

843,941

 

844 

 

28,103 

 

-  

 

-  

 

-  

 

-  

28,947  

 

 

Common stock issued - acquisition of DogeCoin Cash Tokens

 

-

 

- 

 

4,200,000

 

4,200 

 

- 

 

-  

 

-  

 

-  

 

-  

4,200  

 

 

Preferred stock of subsidiary issued - acquisition of DogeCoin Cash Tokens

 

-

 

- 

 

-

 

- 

 

- 

 

-  

 

-  

 

-  

 

7,500,000  

7,500,000  

 

 

Preferred stock issued - dividend payable

 

152,673

 

153 

 

-

 

- 

 

2,588 

 

-  

 

-  

 

-  

 

-  

2,741  

 

 

Preferred stock dividend issued

 

2

 

- 

 

-

 

- 

 

- 

 

-  

 

-  

 

-  

 

-  

-  

 

 

Value of cashless warrants exercised

 

-

 

- 

 

-

 

- 

 

- 

 

45,280  

 

-  

 

-  

 

-  

45,280  

 

 

Common stock issued for services in stock payable

 

-

 

- 

 

3,968,254

 

3,968 

 

58,532 

 

-  

 

-  

 

-  

 

-  

62,500  

 

 

Common stock issued for exercised cashless warrants

 

-

 

- 

 

7,192,913

 

7,192 

 

19,386 

 

(26,578) 

 

-  

 

-  

 

-  

-  

 

 

Net loss for the period

 

-

 

- 

 

-

 

- 

 

- 

 

-  

 

(489,203) 

 

(12,088) 

 

(7,079,850) 

(7,581,141) 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance - September 30, 2025

 

4,652,675

 

$4,653 

 

160,109,029

 

$160,108 

 

$82,337,934 

 

$18,702  

 

$(84,305,776) 

 

$1,297,884  

 

$420,150  

$(66,345) 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nine Months Ended September 30, 2026

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance - January 1, 2026

 

4,652,675

 

$4,653 

 

160,109,029

 

$160,108 

 

$82,337,934 

 

$18,702  

 

$(84,389,964) 

 

$1,291,422  

 

$548,110  

$(29,035) 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock issued for consulting services

 

-

 

- 

 

2,500,000

 

2,500 

 

44,000 

 

-  

 

-  

 

-  

 

-  

46,500  

 

 

Common stock issued - notes payable conversion

 

-

 

- 

 

4,296,737

 

4,297 

 

53,280 

 

-  

 

-  

 

-  

 

-  

57,577  

 

 

Net income (loss) for the period

 

-

 

- 

 

-

 

- 

 

- 

 

-  

 

(558,447) 

 

(18,051) 

 

65,790  

(510,708) 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance - September 30, 2026

 

4,652,675

 

$4,653 

 

166,905,766

 

$166,905 

 

$82,435,214 

 

$18,702  

 

$(84,948,411) 

 

$1,273,371  

 

$613,900  

$(435,666) 

 

 


F-3


DOGECOIN CASH, INC.

 

 

 

 

 

 

 

 

 

 

 

 

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - UNAUDITED

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the nine months ended September 30,

 

2026

 

 

2025

 

 

 

 

 

Cash Flows From Operating Activities:

 

 

 

Net loss for the period

 

$(510,708) 

 

 

$(7,581,141) 

Adjustments to reconcile net loss for the period to net cash

 

 

 

 

 

used in operating activities:

 

 

 

 

 

Allowance for bad debt

 

-  

 

 

75,055  

Unrealized (gain) loss on investments

 

175,956  

 

 

(8,550) 

Impairment expense - digital currency

 

-  

 

 

7,079,850  

Depreciation and amortization

 

813  

 

 

904  

Common stock issued for consulting services

 

46,500  

 

 

-  

Loss on debt settlement

 

38,241  

 

 

16,700  

Professional fee expense paid with note payable conversion

 

-  

 

 

1,458  

Stock payable for services

 

253,125  

 

 

273,274  

Note payable issued for services

 

29,773  

 

 

37,500  

Officer short swing profit repayment

 

-  

 

 

(18,557) 

Warrant cost included in interest expense

 

-  

 

 

45,280  

Account payable converted to note payable

 

-  

 

 

15,843  

Changes in Assets and Liabilities:

 

 

 

 

 

Accounts payable and accrued expenses

 

37,840  

 

 

17,163  

Fair value of convertible component in convertible loans

 

(107,617) 

 

 

(103) 

Accrued interest - related parties

 

11,974  

 

 

8,666  

Net Cash Used in Operating Activities

 

(24,103) 

 

 

(36,658) 

 

 

 

 

 

 

 

Cash Flows from Investing Activities:

 

 

 

 

 

Advances to related party

 

(600) 

 

 

-  

Net Cash Used in Investing Activities

 

(600) 

 

 

-  

 

 

 

 

 

 

 

Cash Flows from Financing Activities:

 

 

 

 

 

Proceeds from related parties notes payable, net

 

4,635  

 

 

31,702  

Net Cash Provided by Financing Activities

 

4,635  

 

 

31,702  

 

 

 

 

 

 

 

NET CHANGE IN CASH

 

(20,068) 

 

 

(4,956) 

 

 

 

 

 

 

 

CASH AT BEGINNING OF PERIOD

 

29,553  

 

 

34,934  

 

 

 

 

 

 

 

CASH AT END OF PERIOD

 

$9,485  

 

 

$29,978  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Supplemental Disclosures of Non Cash Activities:

 

 

 

 

 

 Noncash investing and financing activities

 

 

 

 

 

 Preferred shares issued for divided payable included in stock payable

 

$-  

 

 

$2,741  

 Preferred shares of subsidiary issued in acquisition of digital currency

 

$-  

 

 

$7,500,000  

 Common shares issued in acquisition of digital currency

 

$-  

 

 

$4,200  

 Shares issued in consideration of convertible notes payable

 

$57,577  

 

 

$28,947  

 Common stock issued for consulting services

 

$46,500  

 

 

$15,843  

 

 

 

 

 

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 


F-4


DOGECOIN CASH, INC. 

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended September 30, 2026 and 2025

 

1. Organization and Summary of Significant Accounting Policies 

 

Nature of Business:  

 

Dogecoin Cash Inc. (the “Company,” “us”, “we” or “our”) was incorporated as Ultra Sun Corp. under the laws of Nevada in November 2004.  On November 13, 2013, we changed our name to Cannabis Sativa, Inc. On November 13, 2024, we changed our name to Dogecoin Cash, Inc.   

 

The Company conducts its operations through several subsidiaries, including the following:

 

Operating Subsidiary

 

PrestoCorp, Inc. – a 51% owned subsidiary that represents the Company’s primary operating business and provides telehealth referral services through the PrestoDoctor platform.

 

Digital Asset and Technology Subsidiaries

 

Dogecoin Treasury, Inc. – digital asset treasury and blockchain-related initiatives
DogeSPAC LLC – digital asset acquisition entity
Meme Coins, Inc. – digital asset investment subsidiary

 

Other Wholly Owned Subsidiaries

 

Kubby Patents and Licenses, LLC – intellectual property holdings
Eden Holdings LLC – trademark holdings
Wild Earth Naturals, Inc. – inactive subsidiary
Hi Brands International, Inc. – inactive subsidiary

 

Certain subsidiaries, including DogeSPAC LLC, Meme Coins, Inc., and Dogecoin Treasury, Inc., support the Company’s digital asset acquisition, investment, and treasury management initiatives.

 

PrestoCorp, Inc.  provides telehealth referral services through an online platform that connects patients with licensed physicians in jurisdictions where medical cannabis programs are authorized under applicable state law. Physicians utilizing the platform operate independently and make medical determinations in accordance with applicable state laws and professional medical standards. The Company does not cultivate, distribute, manufacture, or dispense cannabis products and does not participate in the sale of cannabis.

 

The Company’s telehealth platform is designed to comply with applicable privacy and healthcare regulations, including the Health Insurance Portability and Accountability Act (“HIPAA”).

 

Dogecoin Treasury, Inc. is a wholly owned subsidiary of the Company that was formed to hold and manage certain digital asset holdings and related blockchain-based initiatives of the Company. The


F-5


subsidiary may hold digital assets acquired in connection with the Company’s business activities and technology initiatives, which may be maintained directly or through digital asset wallets or custodial service providers. The Company does not operate a digital asset exchange, broker-dealer, or investment fund. Digital assets held by the Company are accounted for in accordance with the Company’s accounting policies described elsewhere in these consolidated financial statements. Additional information regarding the Company’s digital asset holdings is included in Note 5 – Digital Assets.

 

Basis of Presentation

 

Operating results for the three and nine months ended September 30, 2026, may not be indicative of the results expected for the full year ending December 31, 2026. For further information, refer to the financial statements and notes thereto in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

 

The interim financial statements should be read in conjunction with audited financial statements and related footnotes set forth in our annual report filed on Form 10-K for the year ended December 31, 2025, as filed with the United States Securities and Exchange Commission on March 27, 2026.

 

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of the Company’s financial position as of September 30, 2026, and its results of operations, cash flows, and changes in stockholders’ equity for the three and nine months ended September 30, 2026. The financial statements do not include all of the information and notes required by accounting principles generally accepted in the United States (‘GAAP”) for complete financial statements.

 

Principles of Consolidation:

 

The condensed consolidated financial statements include the accounts of Dogecoin Cash, Inc. (the “Company” or “DOGP”), and its wholly-owned subsidiaries and PrestoCorp, a 51% owned subsidiary. All significant inter-company balances have been eliminated in consolidation.

 

Going Concern:

 

The Company has an accumulated deficit of $84,948,411 at September 30, 2026, which, among other factors, raises substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company’s ability to generate profitable operations in the future and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they are due.

 

Use of Estimates:

 

The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Significant estimates and assumptions by management affect the allowance for doubtful accounts, the carrying value of long-lived assets (including goodwill and intangible assets), the provision for


F-6


income taxes and related deferred tax accounts, certain accrued liabilities, revenue recognition, contingencies, and the value attributed to stock-based awards.

 

Net Loss per Share:

 

Basic net loss per share is computed by dividing net loss available to common shareholders by the weighted average number of common shares outstanding for the period and contains no dilutive securities. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of the Company. Potentially dilutive shares are excluded from the calculation of diluted net loss per share because the effect is anti-dilutive. For each of the nine months ended September 30, 2026 and 2025, the Company had 1,954,543 outstanding warrants. At September 30, 2026 and December 31, 2025, the Company has 4,652,675 shares of preferred stock. These would only be dilutive to future period’s net income if they are redeemed by the Company as described in Note 7.

 

Recently Issued Accounting Standards:

 

The Company has implemented all new accounting pronouncements that are in effect and is evaluating any that may impact its financial statements.  The Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

 

2. Intangibles and Goodwill 

 

The Company considers all intangibles to be definite-lived assets with lives of 5 to 15 years. Intangibles consisted of the following at September 30, 2026 and December 31, 2025:  

 

 

 

September 30,

 

 

December 31,

 

 

 

2026

 

 

2025

 

CBDS.com website (Cannabis Sativa)

 

$

13,999

 

 

$

13,999

 

Intellectual Property Rights (PrestoCorp)

 

 

240,000

 

 

 

240,000

 

Patents and Trademarks (KPAL)

 

 

1,281,411

 

 

 

1,281,411

 

Total Intangibles

 

 

1,535,410

 

 

 

1,535,410

 

Less: Accumulated Amortization

 

 

(1,532,838

)

 

 

(1,532,139

)

Net Intangible Assets

 

$

2,572

 

 

$

3,271

 

 

Amortization expense for each of the three months ended September 30, 2026 and 2025 was $233. Amortization expense for each of the nine months ended September 30, 2026 and 2025 was $699.

 

Amortization of intangibles through 2030 is:  

 

October 1, 2026 to September 30, 2027

 

$

932

 

October 1, 2027 to September 30, 2028

 

 

932

 

October 1, 2028 to September 30, 2029

 

 

711

 

 


F-7


Goodwill in the amount of $3,010,202 was recorded as part of the acquisition of PrestoCorp that occurred on August 1, 2017. Cumulative impairment of the PrestoCorp goodwill totals $1,734,391 as of December 31, 2025 and 2024. The balance of goodwill at September 30, 2026 and December 31, 2025 was $1,275,811.  

 

3. Related Party Transactions

 

For the three months ended September 30, 2026 and 2025 officers’ wages were $12,947 and $13,000, respectively. For the nine months ended September 30, 2026 and 2025 officers’ wages were $44,747 and $35,395, respectively. The Company also had consulting and director fee contracts with David Tobias and Cathy Carroll as noted below.  At September 30, 2026 and December 31, 2025, the Company also owed an additional two (2) directors $18,750 for director’s fees that are included in stock payable.

 

Historically, the Company has received funds from borrowings on notes payable and advances from related parties and officers of the Company to cover operating expenses. Related parties include the officers and directors of the Company.

 

Consulting expense to David Tobias, the Company’s chief executive officer and director, for each of the three months ended September 30, 2026 and 2025 was $46,875. At September 30, 2026 and December 31, 2025, the Company owed Mr Tobias $821,875 and $681,250, respectfully for consulting services and director’s fees.  The last payment of these services was in June of 2022. These are included in stock payable at September 30, 2026 and December 31, 2025.

 

At September 30, 2026 and December 31, 2025 the Company owed the Estate of Brad Herr – prior chief financial officer $93,750 in consulting services, and $6,250, respectively in directors fees from his 2022 contract.  These are included in stock payable at September 30, 2026 and December 31, 2025 for a total of $100,000.

 

At September 30, 2026 and December 31, 2025, the Company owed Mr. Bilton, the Company’s chief operating officer, $253,125 in consulting services.  These are included in stock payable at September 30, 2026 and December 31, 2025. The last payment of these services was in June of 2022.  

 

Ms. Carroll has a consulting agreement with the Company in the amount of $12,500, quarterly.  For each of the three months ended September 30, 2026 and 2025 consulting expense was $12,500.  Ms. Carroll has elected that these payments increase her note payable each quarter.

 

During the year ended December 31, 2024, Trevor Reed, a director of the loaned $8,000 to the Company bearing interest at the rate of 10% per annum due on June 4, 2025. If unpaid at June 4, 2025, the interest rate increases to 12% per annum.

 

During the three and nine months ended September 30, 2026 and 2025, David Tobias, the Company’s chief executive officer and director, loaned money to the Company to pay expenses.  This note bears interest at the rate of 5% per annum.

 

Ms. Carroll’s note bears interest at 5% per annum. During the year ended December 31, 2025 Ms. Carroll’s note was increased by her compensation of $12,500 per quarter for a total of $50,000.  


F-8


 

During the three months ended September 30, 2026 and 2025, the Company recorded interest expense related to notes payable to related parties at the rates between 5% and 12% per annum in the amounts of $4,153 and $2,911 respectively. During the nine months ended September 30, 2026 and 2025, the Company recorded interest expense related to notes payable to related parties at the rates between 5% and 12% per annum in the amounts of $11,974 and $8,666 respectively.

 

The following tables reflect the related party note payable balances. 

 

 

 

Related party

Notes and Payables

 

 

Accrued

interest

 

 

Total

 

 

 

September 30, 2026

 

David Tobias, CEO & Director

 

$

32,068

 

 

$

20,646

 

 

$

52,714

 

Cathy Carroll, Director

 

 

251,750

 

 

 

31,934

 

 

 

283,684

 

Trevor Reed, Director

 

 

8,000

 

 

 

1,680

 

 

 

9,680

 

Stock payable – Directors & Officers

 

 

1,193,750

 

 

 

-

 

 

 

1,193,750

 

Totals

 

$

1,485,568

 

 

$

54,260

 

 

$

1,539,828

 

 

 

 

Related party

Notes and Payables

 

 

Accrued

interest

 

 

Total

 

 

 

December 31, 2025

 

David Tobias, CEO & Director

 

$

27,433

 

 

$

19,471

 

 

$

46,904

 

Cathy Carroll, Director

 

 

214,250

 

 

 

21,855

 

 

 

236,105

 

Trevor Reed, Director

 

 

8,000

 

 

 

960

 

 

 

8,960

 

Stock payable – Directors & Officers

 

 

1,053,125

 

 

 

-

 

 

 

1,053,125

 

Totals

 

$

1,302,808

 

 

$

42,286

 

 

$

1,345,094

 

 

At December 31, 2025 the Company had a balance due from MJ Harvest, Inc., with whom the Company had plans to merge, of $75,055, (see Note 9). The amount is included in advances to related party on the consolidated balance sheets. The Company had advanced to MJ Harvest, $75,055 in anticipation of its merger in 2022 and had been trying to collect on this advance.  In April 2025, the Company became aware that MJ Harvest (a related party with common directors) was delisted from the OTC markets, therefore, the Company allowed for the $75,055 it had advanced to MJ Harvest, as the Company is unsure whether the advance will be paid back. The Company is going to continue in its efforts to try to collect on this advance.

 

The Company has an advance to a director of $1,250 at September 30, 2026 and December 31, 2025 that is included in advances to related parties. The funds were advanced to the director to cover consulting services.  During the nine months ended September 30, 2026, the Company advanced


F-9


$600 to a company with which David Tobias is also a Board Member.  Total advances to related parties at September 30, 2026 and December 31, 2025 was $1,850 and $1,250, respectively.

 

4. Investments

 

CBDG

In 2021, the Company received 1,500,000 shares common stock of THC Pharmaceuticals Inc. (ticker: CBDG). The CBDG shares were received as consideration for the sale of the Company’s majority interest in iBud and GKMP in the year ended December 31, 2021. On the date of sale, the shares were valued at fair value which was $0.20 per share or $600,000 in the aggregate. The Company’s Chief Executive Officer and Chairman of the Board, David Tobias is a Director of CBDG.

 

The Company’s investment in CBDG represents 15% of CBDG’s voting shares on a fully diluted basis which, coupled with Mr. Tobias’ position as a director and his individual investment in CBDG, results in the Company having significant influence over CBDG.  The Company elected to account for its investment in CBDG at fair value because the Company does not intend to hold the investment for a long period of time and the shares are readily marketable. The fair value of the Company’s investment at September 30, 2026 and December 31, 2025 was $36,000 and $57,000 resulting in an unrealized gain (loss) of $19,500 and $8,100 for the change in fair value for the three months ended September 30, 2026 and 2025, respectively and ($21,000) and $8,550 for the nine months ended September 30, 2026 and 2025, respectively.

 

5. Digital Assets

 

The Company maintains digital asset treasury holdings consisting primarily of Dogecoin Cash ($DOG) tokens obtained through strategic corporate transactions.

 

Digital Asset Strategy

 

The Company holds digital assets consisting primarily of Dogecoin Cash ($DOG) tokens that were acquired through strategic corporate transactions with affiliated entities and third parties. Certain digital assets are held through the Company’s wholly owned subsidiaries Meme Coins, Inc. and Dogecoin Treasury, Inc., which were formed to hold and manage digital asset investments and treasury activities.

 

Digital assets may represent a potential component of the Company’s broader technology and blockchain-related initiatives.

 

The Company does not currently operate a digital asset trading business and does not actively engage in the purchase or sale of digital assets for speculative trading purposes.

 

Accounting for Digital Assets

 

Management has evaluated the applicability of Accounting Standards Update No. 2023-08, Accounting for and Disclosure of Crypto Assets, codified under ASC 350-60, to the Dogecoin Cash (DOG) tokens held by the Company and its consolidated subsidiaries as of September 30, 2026. The Company and management has determined that the qualifying DOG token holdings are subject to measurement at fair value as of September 30, 2026, with changes in fair value recognized in


F-10


earnings, consistent with ASC 350-60 and are therefore subject to the accounting and disclosure provisions of ASU 2023-08.

 

The DOG tokens were initially recorded at cost based on the fair value of consideration transferred in connection with the acquisition of DogeSPAC LLC. These assets were not remeasured upward for increases in market value but were evaluated for impairment through December 31, 2025, depending on events or changes in circumstances indicated that the carrying amount may not be recoverable. The Company did not remeasure these tokens during the quarters ended March 31 or June 30, 2026, therefore the Company remeasured both these quarters during the quarter ended September 30, 2026, and adjusted the Statement of Stockholders Deficit accordingly (See Note 10).

 

Digital Asset Holdings

 

As of September 30, 2026 and December 31, 2025, the Company held approximately 8,020,000,000 DOG tokens through its subsidiaries DogeSPAC LLC, Meme Coins, Inc., and Dogecoin Treasury, Inc. At September 30, 2026, the fair market value of these tokens was $703,354. At December 31, 2025, the tokens were carried at cost of $858,310. Unrealized income for the three months ended September 30, 2026 and 2025 was $189,272 and $-0-, respectively.   Unrealized loss for the nine months ended September 30, 2026 and 2025, was $154,956 and $-0-, respectively.

 

These digital assets were recorded at historical cost at December 31, 2025.

 

The Company believes that digital assets obtained through strategic corporate transactions may provide long-term strategic optionality in connection with the Company’s technology and blockchain-related initiatives.

 

On May 22, 2025, the Company entered into an agreement with Bots, Inc to purchase 420,000,000 Dogecoin Cash tokens in exchange for 4,200,000 shares of the Company’s common stock. This acquisition was valued at $4,200 and the shares were issued to Bots, Inc on June 12, 2025.

 

On June 25, 2025, Meme Coins Inc., a 100% controlled subsidiary of Dogecoin Cash, Inc. entered into a definitive Digital Asset Purchase Agreement with Tipestry, Inc., a Delaware corporation. Pursuant to the agreement, Meme Coins agreed to acquire 3,000,000,000 Dogecoin Cash tokens (crypto symbol: DOG) in exchange for 375,000 shares of Meme Coins Inc.’s preferred stock. The preferred shares entitle the holder to one vote per share and are non-convertible unless authorized by the board of directors and approved by a majority of the outstanding Class A Preferred shareholders.  The par value of the preferred stock is $20 therefore the cost of the acquired Dogecoin cash tokens were valued at $7,500,000.  Due to the same factors of instability in the coin, the value of the coins were discounted by 95% to the lowest closing value of the coin from the acquisition to the end of the September 30th quarter which was $0.002801, which calculated to an impairment of the investment in the coins in the amount of $7,079,850 as reported in the statement of operations for the year ended December 31, 2025 attributable 100% to the non-controlling interest in Meme Coins Inc.

 

On October 29, 2025, Meme Coins Inc., a 100% controlled subsidiary of Dogecoin Cash, Inc. entered into a definitive Digital Asset Purchase Agreement with Tipestry, Inc., a Delaware corporation. Pursuant to the agreement, Meme Coins agreed to acquire 4,000,000,000 Dogecoin Cash tokens (crypto symbol: DOG) in exchange for 125,000 shares of Meme Coins Inc.’s preferred stock. The


F-11


preferred shares entitle the holder to one vote per share and are non-convertible unless authorized by the board of directors and approved by a majority of the outstanding Class A Preferred shareholders.  The par value of the preferred stock is $20 therefore the cost of the acquired Dogecoin cash tokens were valued at $2,500,000.  Due to the same factors of instability in the coin, the value of the coins were discounted by 95% to the closing value of the coin at acquisition which was $0.0006398, which calculated to an impairment of the investment in the coins in the amount of $2,372,040 which is reported in the statement of operations for the year ended December 31, 2025 attributable 100% to the non-controlling interest in Meme Coins Inc.

 

6. Convertible Notes Payable 

 

The Company has issued convertible notes to various lenders including related parties. These notes bear interest at rates ranging from 5% to 12% per annum and may be convertible into common stock under specified terms. At September 30, 2026 and December 31, 2025 convertible notes payable was $159,918 and $183,270, respectively. During the period ended September 30, 2026 a note in the amount of $15,625 and accrued interest was converted into common shares.  During the period ended September 30, 2026, a note payable was reduced in the amount of $7,727 because it was discovered the original note balance which was transferred from stock payable included the original discount. Derivative liabilities are associated with these convertible notes.  The notes are convertible at a 30% discount rate, utilizing the average of the three (3) lowest closing prices during the 30 days prior to the request for conversion.  At September 30, 2026 and December 31, 2025, derivative liabilities were $66,770 and $174,387, respectively.  For the three months ended September 30, 2026 and 2025 change in derivative liabilities were $107,617 and $-0-, respectively.  For the nine months ended September 30, 2026 and 2025 change in derivative liabilities were $107,617 and $-0-, respectively.  

 

At September 30, 2026 and December 31, 2025, accrued interest payable on these notes was $48,098 and $39,112, respectively. Accrued interest payable is included in accounts payable and accrued expenses on the consolidated balance sheet. Interest expense for the three months ended September 30, 2026 and 2025 was $4,718 and $5,116, respectively and $12,695 and $12,460, respectively for the nine months ended September 30, 2026 and 2025.  An reduction of $2,704 was also posted during the period ended September 30, 2026 adjusting interest due to the incorrect note balance that was corrected due to discount (See above).

 

7. Stockholders’ Equity

 

Common Stock

 

The Company is authorized to issue 495,000,000 shares of common stock.

 


F-12


 

Preferred Stock

 

Series A Preferred Stock

 

The Company is authorized to issue 5,000,000 Series A Preferred Stock at a par value of $0.001 per share. Each share is entitled to one (1) vote, is not convertible into common stock, but have liquidation preference of $1.00 per share, plus any declared but unpaid dividends.

 

Each share of Series A Preferred Stock entitles the holder to receive, if and when declared by the Board of Directors, one (1) share of common stock per annum as a dividend, provided the holder owns the share on November 25 of the applicable year. The dividend is non-cumulative and payable solely in common stock.  For the year ended December 31, 2025 no dividend was declared.

 

The Series A Preferred Stock may be redeemed, at the option of the Company, at any time on or before October 25, 2034, by issuing ten (10) shares of common stock for each one (1) share of Series A Preferred Stock outstanding. As of September 30, 2026 and December 31, 2025, no redemptions have been declared or effected.

 

Securities Issuances

 

Stock payable at September 30, 2026 and December 31, 2025 consists of restricted common shares owed to members of the board of directors for directors’ fees and contract services.  These shares were valued at $1,193,750 and $1,053,125, respectively based on the fair value of the Company’s common stock at the date of board authorization.  An additional amount of common shares are owed to various non-related vendors at September 30, 2026 and December 31, 2025 valued at $475,423 and $362,922 based on the fair value of the Company’s common stock at the date of board authorization.

 

During the year ended December 31, 2025, 843,941 shares of common stock were issued to convert $10,831 of a note payable, $-0- of accrued interest and $1,457 of fees. The note was converted at an applicable conversion rate of $0.014560. Market value at date of conversion was $0.0343 which produced a loss on debt settlement of $16,700.  

 

During the year ended December 31, 2025 the Company issued 4,200,000 shares of common stock in exchange for 420,000,000 Dogecoin Cash Tokens.

 

During the year ended December 31, 2025 the Company issued 3,968,254 shares of common stock for services that were previously recorded in stock payable valued at $62,500.

 

During the year ended December 31, 2025 the Company issued 7,192,913 shares of common stock for exercised cashless warrants valued at $26,578.

 

During the nine months ended September 30, 2026, 4,296,737 shares of common stock were issued to convert $15,625 of a note payable, $3,710 of accrued interest. The note was converted at an applicable conversion rate of $0.0045. Market value at date of conversion was $0.0134 which produced a loss on debt settlement of $38,241.  


F-13


 

Stock Compensation Plans

 

2020 Stock Plan

 

On September 25, 2020, the Company adopted the Cannabis Sativa 2020 Stock Plan which authorized the Company to utilize common stock to compensate employees, officers, directors, and independent contractors for services provided to the Company. By resolution dated September 25, 2020, the Company authorized up to 1,000,000 shares of common stock to be issued pursuant to the 2020 Stock Plan. This amount was subsequently increased to 2,000,000 shares on January 27, 2021. At September 30, 2026 and December 31, 2025, 44,425 shares were available for future issuance.

 

8. Commitments and Contingencies

 

Litigation.

 

In the ordinary course of business, we may face various claims brought by third parties and we may, from time to time, make claims or take legal actions to assert our rights, including intellectual property disputes, contractual disputes and other commercial disputes. Any of these claims could subject us to litigation. As of September 30, 2026, no claims are outstanding.

 

9. Proposed Merger with MJ Harvest, Inc.

 

On August 8, 2022, the Company entered into a Merger Agreement (the “Merger Agreement”) with MJ Harvest, Inc. (“MJHI”). Pursuant to the Merger Agreement, MJHI will merge with and into the Company and the Company will be the surviving corporation in the Merger. The Merger was expected to be consummated once the shareholders of the Company and the shareholders of MJHI approved the Merger which management had expected will be completed early in the second quarter of calendar year 2023.

 

The merger was withdrawn with the SEC in August 2023.  As of December 31, 2024, the merger has effectively been abandoned.  Though not formally withdrawn the deal is effectively stalled without any further progress. The Company and MJ Harvest may continue discussions in the future in hopes of completing the transaction.

 

In April 2025, the Company became aware that MJ Harvest (a related party with common directors) was delisted from the OTC markets.  The Company had advanced to MJ Harvest $75,055 in anticipation of its merger in 2022 and had been trying to collect on this advance.  In April 2025, the Company allowed for the $75,055 it had advanced to MJ Harvest, as the Company is unsure whether the advance will be paid back. The Company is going to continue in its efforts to try to collect on this advance.


F-14


 

10. Other Matters

 

Restatement of March 31, 2026 and June 30, 2026 10Qs.

 

The Company will restate their 10Q filings for the periods ended March 31, 2026 and June 30,2026 to account for the fair market remeasurement of DOG Tokens.  The following is the effect the changes had on the statement of Stockholders’ Deficit:

 

 

 

Accumulated

Non-controlling

Total Deficit

Change Income

 

 

Deficit

Interest

 

(Expense)

 

 

 

Meme Coins Inc

 

 

 

 

 

 

 

 

Net Loss - Original as Filed

3.31.2026

$ (84,587,856)

 $ 548,110

$ (183,005)

 

Net Income (Loss) - Restated

3.31.2026

$ (84,769,128)

 $ 884,800

$ (27,587)

$ 155,418 

 

 

 

 

 

 

Net Loss - Original as Filed

6.30.2026

$ (84,714,880)

 $ 548,110

$ (320,711)

 

Net Income (Loss) - Restated

6.30.2026

$ (84,959,698)

 $ 448,700

$ (664,939)

$ (344,228)

 

11. Subsequent Events 

 

On October 2, 2026, the Company entered into a convertible note payable with a non related party.  The note converted $22,733.84 of accounts payable into a one (1) year note earning interest at ten (10%) per annum.  

 

On November 3, 2026, the Company registered its DogeCoin Cash Units under Section 12(g) of the Securities and Exchange Act of 1934, as amended. The Units are governed by the Certificate of Designation of Dogecoin Cash Inc. Units filed with the Nevada Secretary of State on January 7, 2026, as Filing No. 20265428585, effective January 7, 2026.

 

The Units are contractual securities of the Company, separate from the Company’s common and preferred stock and from the underlying blockchain tokens. Each Unit represents a contractual right, exercisable subject to the Designation, to withdraw one (1) Dogecoin Cash digital token (a “DOG Token”).

 

The Units have no stated or par value. They do not represent shares of capital stock, partnership interests, direct equity ownership, voting rights or residual ownership interests in the Company. They confer no dividend or governance rights. The Designation does not provide for conversion of Units into Company capital stock or for preemptive or subscription rights.

 

On November 3, 2026, PrestoCorp Inc., received an eviction notice for its New York City rental space with WeWork.  The Company has determined that the loss of this office space will not affect PrestoCorp’s operations.


F-15